Michael E. Lassman

4.9k total citations · 1 hit paper
45 papers, 3.2k citations indexed

About

Michael E. Lassman is a scholar working on Molecular Biology, Spectroscopy and Biomedical Engineering. According to data from OpenAlex, Michael E. Lassman has authored 45 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Spectroscopy and 7 papers in Biomedical Engineering. Recurrent topics in Michael E. Lassman's work include Advanced Proteomics Techniques and Applications (12 papers), Mass Spectrometry Techniques and Applications (10 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Michael E. Lassman is often cited by papers focused on Advanced Proteomics Techniques and Applications (12 papers), Mass Spectrometry Techniques and Applications (10 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Michael E. Lassman collaborates with scholars based in United States, Australia and Denmark. Michael E. Lassman's co-authors include Igor L. Medintz, Ellen R. Goldman, Chris R. Taitt, Frances S. Ligler, Andrew Hayhurst, Jeffrey R. Deschamps, F. Stephen Hodi, Robert H.I. Andtbacka, Georgina V. Long and Lisa Chen and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael E. Lassman

45 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

2017 1.1k citations Antoni Ribas, Reinhard Dummer et al. Cell profile →

Peers

Countries citing papers authored by Michael E. Lassman

Since Specialization

Citations

This map shows the geographic impact of Michael E. Lassman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Lassman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Lassman more than expected).

Fields of papers citing papers by Michael E. Lassman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Lassman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Lassman. The network helps show where Michael E. Lassman may publish in the future.

Co-authorship network of co-authors of Michael E. Lassman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Lassman. A scholar is included among the top collaborators of Michael E. Lassman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Lassman. Michael E. Lassman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy breakdown → 2017 ·Cell ·Antoni Ribas, Reinhard Dummer, Igor Puzanov, Ari M. Vanderwalde, Robert H.I. Andtbacka, Olivier Michielin, Anthony J. Olszanski, Josep Malvehy, Jonathan Cebon, Eugenio Fernández, John M. Kirkwood, Thomas F. Gajewski, Lisa Chen, Kevin Gorski, Abraham Anderson, Scott J. Diede, Michael E. Lassman, Jennifer Gansert, F. Stephen Hodi, Georgina V. Long	1142
2	The clinical utility of mass spectrometry based protein assays 2016 ·Clinica Chimica Acta ·Michael E. Lassman, Thomas McAvoy, Derek L Chappell, (unknown), (unknown), Omar Laterza	10
3	An LC-Mrm Method for Measuring Intestinal Triglyceride Assembly Using an Oral Stable Isotope-Labeled Fat Challenge 2016 ·Bioanalysis ·Xiaofang Li, Elizabeth J. Parks, David G. McLaren, Jennifer E. Lambert, Helene L. Cardasis, Derek L Chappell, Thomas McAvoy, Gino Salituro, Achilles Alon, (unknown), Manu V. Chakravarthy, Sudha S. Shankar, Omar Laterza, Michael E. Lassman	3
4	Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test 2015 ·Clinical Chemistry ·Anita Y. H. Lee, Derek L Chappell, Monika Bąk, Michael Judo, Linda Liang, Tatyana Churakova, Gulesi Ayanoglu, José Castro‐Perez, Haihong Zhou, Stephen F. Previs, Sandra C. Souza, Michael E. Lassman, Omar Laterza	39
5	Practical Immunoaffinity-Enrichment LC-MS for Measuring Protein Kinetics of Low-Abundance Proteins 2014 ·Clinical Chemistry ·Michael E. Lassman, Thomas McAvoy, Anita Y. H. Lee, Derek L Chappell, (unknown), Haihong Zhou, Gissette Reyes‐Soffer, Henry N. Ginsberg, John S. Millar, Daniel J. Rader, David E. Gutstein, Omar Laterza	29
6	Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS 2014 ·Journal of Lipid Research ·Yi Pan, Haihong Zhou, Ablatt Mahsut, Rory J. Rohm, (unknown), (unknown), Ying Chen, José Castro‐Perez, Michael E. Lassman, David G. McLaren, James Conway, Kristian K. Jensen, Tiffany Thomas, Gissette Reyes‐Soffer, Henry N. Ginsberg, David E. Gutstein, Michele A. Cleary, Stephen F. Previs, Thomas P. Roddy	17
7	Quantitation of Human Peptides and Proteins Via MS: Review of Analytically Validated Assays 2014 ·Bioanalysis ·Derek L Chappell, Michael E. Lassman, Thomas McAvoy, Mingxiang Lin, Daniel S. Spellman, Omar Laterza	26
8	Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry 2014 ·Clinical Chemistry ·Thomas McAvoy, Michael E. Lassman, Daniel S. Spellman, (unknown), Bonnie J. Howell, (unknown), (unknown), Michael Tanen, Arie Struyk, Omar Laterza	59
9	Quantifying apoprotein synthesis in rodents: coupling LC-MS/MS analyses with the administration of labeled water 2012 ·Journal of Lipid Research ·Haihong Zhou, Wenyu Li, Sheng-Ping Wang, Vivienne Mendoza, Raymond Rosa, James Hubert, Kithsiri Herath, (unknown), Rory J. Rohm, Michael E. Lassman, Kenny K. Wong, Douglas G. Johns, Stephen F. Previs, Brian K. Hubbard, Thomas P. Roddy	20
10	An ultraperformance liquid chromatography method for the normal-phase separation of lipids 2011 ·Analytical Biochemistry ·David G. McLaren, Paul L. Miller, Michael E. Lassman, José Castro‐Perez, Brian K. Hubbard, Thomas P. Roddy	41
11	Equilibration of 2H labeling between body water and free amino acids: Enabling studies of proteome synthesis 2011 ·Analytical Biochemistry ·Kithsiri Herath, (unknown), Paul L. Miller, Shengping Wang, (unknown), (unknown), Christopher Johnson, Rory J. Rohm, Michael E. Lassman, Stephen F. Previs, Douglas G. Johns, Brian K. Hubbard, Thomas P. Roddy	16
12	Validation of Human ApoB and ApoAI Immunoturbidity Assays for Non-human Primate Dyslipidemia and Atherosclerosis Research 2011 ·Journal of Cardiovascular Translational Research ·Zhu Chen, Alison M. Strack, (unknown), Ying Chen, Weizhen Wu, Yi Pan, (unknown), Li Wang, (unknown), Neil S. Geoghagen, Michael E. Lassman, Thomas P. Roddy, Kenny K. Wong, Brian K. Hubbard, Amy Flattery	8
13	Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities 2010 ·Bioorganic & Medicinal Chemistry Letters ·Haifeng Tang, (unknown), Zhe Feng, (unknown), Lihu Yang, Dorothy Levorse, Karen Owens, Taro E. Akiyama, Raynald Bergeron, Gino Castriota, Thomas W. Doebber, Kenneth Ellsworth, Michael E. Lassman, Li Cai, Margaret Wu, Bei B. Zhang, Kevin T. Chapman, Sander G. Mills, Joel P. Berger, Alexander Pasternak	13
14	Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase 2010 ·PROTEOMICS ·Xuemei Zhao, Katie Southwick, Helene L. Cardasis, Yi Du, Michael E. Lassman, Dan Xie, (unknown), Wayne M. Geissler, KellyAnn D. Pryor, Andreas Verras, Margarita García‐Calvo, Dong‐Ming Shen, Nathan A. Yates, Shirly Pinto, (unknown)	8
15	Indirect competitive immunoassay for detection of aflatoxin B1 in corn and nut products using the array biosensor 2006 ·Biosensors and Bioelectronics ·Kim E. Sapsford, Chris R. Taitt, Stephanie J. Fertig, M. H. Moore, Michael E. Lassman, Chris M. Maragos, Lisa C. Shriver‐Lake	93
16	Detection of Deoxynivalenol in Foods and Indoor Air Using an Array Biosensor 2006 ·Environmental Science & Technology ·Miriam M. Ngundi, (unknown), (unknown), M. H. Moore, Michael E. Lassman, Lisa C. Shriver‐Lake, Frances S. Ligler, Chris R. Taitt	60
17	Antimicrobial Peptides for Detection of Bacteria in Biosensor Assays 2005 ·Analytical Chemistry ·Nadezhda V. Kulagina, Michael E. Lassman, Frances S. Ligler, Chris R. Taitt	143
18	Fragmentation of biotinylated cyclic peptides 2004 ·Rapid Communications in Mass Spectrometry ·Michael E. Lassman, (unknown), Chris R. Taitt	5
19	A Fluorescence Resonance Energy Transfer Sensor Based on Maltose Binding Protein 2003 ·Bioconjugate Chemistry ·Igor L. Medintz, Ellen R. Goldman, Michael E. Lassman, J. Matthew Mauro	90
20	Evidence for iron, copper and zinc complexation as multinuclear sulphide clusters in oxic rivers 2000 ·Nature ·Tim F. Rozan, Michael E. Lassman, D. P. Ridge, George W. Luther	187

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact